IRIS
CONTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.202
EU - Europa 1.172
AS - Asia 761
SA - Sud America 189
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 4.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.174
SG - Singapore 298
UA - Ucraina 202
CN - Cina 191
IT - Italia 187
BR - Brasile 159
SE - Svezia 153
DE - Germania 149
RU - Federazione Russa 112
IE - Irlanda 110
TR - Turchia 92
DK - Danimarca 72
FI - Finlandia 57
CI - Costa d'Avorio 49
GB - Regno Unito 47
VN - Vietnam 46
KR - Corea 39
HK - Hong Kong 38
FR - Francia 30
IN - India 22
CA - Canada 14
NL - Olanda 14
PL - Polonia 12
MX - Messico 11
AR - Argentina 10
JP - Giappone 8
ZA - Sudafrica 8
EC - Ecuador 7
ES - Italia 7
MA - Marocco 7
ID - Indonesia 6
BE - Belgio 5
EU - Europa 5
AT - Austria 4
CO - Colombia 4
LT - Lituania 4
BD - Bangladesh 3
EG - Egitto 3
IQ - Iraq 3
CL - Cile 2
PE - Perù 2
PK - Pakistan 2
RS - Serbia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CY - Cipro 1
EE - Estonia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 4.398
Salva come PNG Salva come JPEG
Città #
Ashburn 259
Chandler 221
Jacksonville 212
Singapore 183
Fairfield 176
Dublin 110
New York 103
Wilmington 101
Boardman 90
Seattle 84
Woodbridge 84
Dallas 82
Beijing 76
Abidjan 49
Houston 47
Cambridge 44
Lawrence 43
Princeton 43
San Mateo 43
Hong Kong 38
Munich 37
Centro 36
Los Angeles 33
Ann Arbor 31
The Dalles 30
Ho Chi Minh City 21
San Diego 20
Moscow 18
Hefei 15
London 15
São Paulo 15
Turku 15
Turin 14
Brooklyn 11
Chicago 11
Warsaw 11
Guangzhou 10
Hanoi 9
Helsinki 9
Des Moines 8
Marche 8
Pune 8
Rome 8
Tokyo 8
Buffalo 7
Chennai 7
Redmond 7
Rio de Janeiro 7
Shanghai 7
Stockholm 7
Johannesburg 6
Montegiorgio 6
Montreal 6
Poplar 6
Porto Alegre 6
Santa Clara 6
Wuxi 6
Ancona 5
Brussels 5
Cupra Marittima 5
Manchester 5
Norwalk 5
Porto 5
Washington 5
Atlanta 4
Belo Horizonte 4
Curitiba 4
Frankfurt am Main 4
Jiaxing 4
Nuremberg 4
Orem 4
Phoenix 4
Toronto 4
Amsterdam 3
Ankara 3
Boston 3
Brasília 3
Chiswick 3
Columbus 3
Izmir 3
Kilburn 3
Mexico City 3
Miami 3
Milan 3
Portland 3
Querétaro 3
Rapagnano 3
San Francisco 3
Santa Cruz 3
Thái Nguyên 3
Tolentino 3
Vienna 3
Aracaju 2
Baghdad 2
Berlin 2
Betim 2
Biên Hòa 2
Cairo 2
Calgary 2
Campo Grande 2
Totale 2.717
Salva come PNG Salva come JPEG
Nome #
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 162
Emerging biomarkers in bladder cancer identified by network analysis of transcriptomic data 154
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 149
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 148
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 141
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 140
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 132
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 127
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 127
Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience 125
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 124
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 122
Metabolic Alterations in Renal and Prostate Cancer 121
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 118
PEC-OME of the prostate: case report 112
NEPHRON-SPARING SURGERY FOR RENAL MASSES >4 CM (CT1B-T2) IN PATIENTS WITH CHRONIC RENAL FAILURE 108
Diagnostic-therapeutic pathway for small lesions of the testis 107
Urinary catheters and biofilm formation 106
Present and future of personalized medicine in adult genitourinary tumors 105
Biomarkers for VEGF-targeted therapy in renal cell carcinoma: an UpTo Date 103
Repeated injection of botulinum toxin a in patients with neurogenic bladder: our experience. 101
Sphincter: properties, types and application 101
Neuroendocrine differentiation in prostate cancer: novel morphological insights and future therapeutic perspectives. 99
Targeted therapy for solid tumors and risk of hypertension: a meta-analysis of 68077 patients from 93 phase III studies 99
Emerging concepts on drug resistance in bladder cancer: Implications for future strategies 98
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients 96
The route to personalized medicine in bladder cancer: where do we stand? 93
New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials 92
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: A systematic review and meta-analysis 91
Efficacy and safety of alfa-1-blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a prospective study 90
Role of STAT3 pathway in genitourinary tumors 90
Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma 89
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy 87
Recurrent urinary tract infections and dysfunctional voiding 83
Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors 82
α1-Blockers for the treatment of recurrent urinary tract infections in women with dysfunctional voiding: A prospective randomized study. 80
Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasis 77
RESULTS OF NEPHRON-SPARING SURGERY WITHOUT VASCULAR CLAMPING IN PATIENTS WITH CHRONIC RENAL FAILURE 71
VEGF and HIF in renal cell carcinogenesis. 70
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma 68
Survival in Patients with Clear Cell Renal Cell Carcinoma is Predicted by HIF-1α Expression 67
Re: Gut Microbiome Influences Efficacy of PD-1-based Immunotherapy Against Epithelial Tumors 64
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma 57
Totale 4.476
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021429 0 0 0 0 0 34 66 60 77 82 73 37
2021/2022306 33 60 8 9 2 26 5 15 24 28 24 72
2022/2023636 58 94 44 48 48 53 3 40 168 8 48 24
2023/2024419 75 7 28 47 56 131 8 12 3 9 1 42
2024/2025710 101 53 11 10 54 22 62 21 145 43 87 101
2025/2026925 169 141 80 182 256 97 0 0 0 0 0 0
Totale 4.476